INmune Bio Inc. Company Profile, Contacts & Intelligence

INmune Bio Inc. Overview

INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease. Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.

Headquarters

255 Ne Mizner B

Website

inmunebio.com

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

INmune Bio Inc. Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

INmune Bio Inc. People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

INmune Bio Inc. Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to INmune Bio Inc.

Explore companies in related markets and compare their industry and employee estimates.